Log in to save to my catalogue

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits p...

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits p...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2775624112

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

About this item

Full title

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2023-03, Vol.42 (11), p.859-859

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Alternative Titles

Full title

Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2775624112

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2775624112

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/s41388-023-02608-7

How to access this item